Anbio Biotechnology NNNN
NASDAQ NNNN
$3.71 -0.01 (-0.27%)
At close: Oct 22, 2026 · 4:00 PM EDT

Anbio Biotechnology (NNNN) Liabilities and Shareholders Equity (2023 - 2025)

Updated

Anbio Biotechnology (NNNN) posted Liabilities and Shareholders Equity of $30.24 million for the quarter ended Dec 31, 2025, up 59.8% from $18.92 million a year earlier.

Analysis

Anbio Biotechnology (NNNN) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends

Since the quarter ended Dec 31, 2023, Anbio Biotechnology has reported Liabilities and Shareholders Equity for 4 quarters.

  • In prior years, Anbio Biotechnology's Liabilities and Shareholders Equity was $18.92 million in the year ended Dec 31, 2024 (+19.7%) and $15.81 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 250.06 Bn 229.21 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 177.62 Bn 148.71 Bn 7.27 Bn 109.22 Bn
3 Danaher 161.58 Bn 145.40 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 153.84 Bn 134.26 Bn 2.08 Bn 19.35 Bn
5 Medtronic 123.63 Bn 89.50 Bn 6.34 Bn 93.31 Bn
6 Stryker 117.79 Bn 103.90 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 66.71 Bn 61.72 Bn 3.85 Bn 45.22 Bn
8 Becton Dickinson 54.60 Bn 51.75 Bn 2.32 Bn 50.73 Bn
9 Edwards Lifesciences 51.95 Bn 36.07 Bn 1.35 Bn 13.87 Bn
10 Anbio Biotechnology 533.84 Mn 487.06 Mn - 30.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 30.24 Mn
Jun 30, 2025 27.68 Mn
Dec 31, 2024 18.92 Mn
Dec 31, 2023 15.81 Mn
API Access

Anbio Biotechnology Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NNNN&period=max&api_key=YOUR_API_KEY